250
Participants
Start Date
August 31, 2015
Primary Completion Date
March 6, 2020
Study Completion Date
June 3, 2021
Avapritinib
avapritinib tablets
Leuven Cancer Institute University Hospitals Leuven, Leuven
Erasmus MC Cancer Institute, Rotterdam
Memorial Sloan Kettering Cancer Center, New York
Fox Chase Cancer Center, Philadelphia
Fondazione IRCCS - Istituto Nazinale dei Tumori, Milan
Cancer Treatment Centers of America, Atlanta
Sylvester Comprehensive Cancer Center, Miami
University of Duisburg-Essen, Essen
Centre Leon Berard, Lyon
MD Anderson Cancer Center, Houston
Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale
Sarcoma Oncology Center, Santa Monica
Institut Gustave Roussy, Paris
Oregon Health and Science University, Portland
Dana Farber Cancer Institute, Boston
Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w Warszawie, Warsaw
Asan Medical Center, Seoul
Vall d' Hebron Institute of Oncology (VHIO), Barcelona
Royal Marsden Hospital, London
Lead Sponsor
Blueprint Medicines Corporation
INDUSTRY